Inactivation of KDM5A suppresses growth and enhances chemosensitivity in liver cancer by modulating ROCK1/PTEN/AKT pathway-Reference-Cited by-同舟云学术

Inactivation of KDM5A suppresses growth and enhances chemosensitivity in liver cancer by modulating ROCK1/PTEN/AKT pathway

Published:2023-02 Issue: Volume:940 Page:175465
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Fang Shiji,Zheng Liyun,Shen Lin,Su Yanping,Ding Jiayi,Chen Weiyue,Chen Xiaoxiao,Chen Weiqian,Shu Gaofeng,Chen Minjiang,Zhao Zhongwei,Tu Jianfei,Ji Jiansong

Publisher

Elsevier BV

Subject

Pharmacology

Reference32 articles.

1. Recent updates of transarterial chemoembolilzation in hepatocellular carcinoma;Chang;Int. J. Mol. Sci.,2020

2. Revisiting hepatic artery infusion chemotherapy in the treatment of advanced hepatocellular carcinoma;Chen;Int. J. Mol. Sci.,2021

3. The role of histone methylation in the development of digestive cancers: a potential direction for cancer management;Chen;Signal Transduct. Targeted Ther.,2020

4. Rho GTPase signaling in cancer progression and dissemination;Crosas-Molist;Physiol. Rev.,2022

5. ROCK1 mechano-signaling dependency of human malignancies driven by TEAD/YAP activation;Esposito;Nat. Commun.,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Steatotic liver disease induced by TCPOBOP-activated hepatic constitutive androstane receptor: primary and secondary gene responses with links to disease progression;Toxicological Sciences;2024-05-06

2. Steatotic liver disease induced by TCPOBOP-activated hepatic constitutive androstane receptor: Primary and secondary gene responses with links to disease progression;2024-02-20

3. Epigenetic regulation in cancer therapy: From mechanisms to clinical advances;MedComm – Oncology;2024-01-04